244 related articles for article (PubMed ID: 21956723)
1. ALS clinical trials: do enrolled patients accurately represent the ALS population?
Chiò A; Canosa A; Gallo S; Cammarosano S; Moglia C; Fuda G; Calvo A; Mora G;
Neurology; 2011 Oct; 77(15):1432-7. PubMed ID: 21956723
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of ALS in Italy: a 10-year prospective population-based study.
Chiò A; Mora G; Calvo A; Mazzini L; Bottacchi E; Mutani R;
Neurology; 2009 Feb; 72(8):725-31. PubMed ID: 19237701
[TBL] [Abstract][Full Text] [Related]
3. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Lyon M; Moore DH
Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
[TBL] [Abstract][Full Text] [Related]
4. Predictors of delay in the diagnosis and clinical trial entry of amyotrophic lateral sclerosis patients: a population-based study.
Zoccolella S; Beghi E; Palagano G; Fraddosio A; Samarelli V; Lamberti P; Lepore V; Serlenga L; Logroscino G;
J Neurol Sci; 2006 Dec; 250(1-2):45-9. PubMed ID: 16920152
[TBL] [Abstract][Full Text] [Related]
5. The ALSFRSr predicts survival time in an ALS clinic population.
Kaufmann P; Levy G; Thompson JL; Delbene ML; Battista V; Gordon PH; Rowland LP; Levin B; Mitsumoto H
Neurology; 2005 Jan; 64(1):38-43. PubMed ID: 15642901
[TBL] [Abstract][Full Text] [Related]
6. Secular Trends of Amyotrophic Lateral Sclerosis: The Piemonte and Valle d'Aosta Register.
Chiò A; Mora G; Moglia C; Manera U; Canosa A; Cammarosano S; Ilardi A; Bertuzzo D; Bersano E; Cugnasco P; Grassano M; Pisano F; Mazzini L; Calvo A;
JAMA Neurol; 2017 Sep; 74(9):1097-1104. PubMed ID: 28692730
[TBL] [Abstract][Full Text] [Related]
7. [Revised amyotrophic lateral sclerosis functional rating scale at time of diagnosis predicts survival time in amyotrophic lateral sclerosis].
Liu XX; Fan DS; Zhang J; Zhang S; Zheng JY
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(35):2472-5. PubMed ID: 20137433
[TBL] [Abstract][Full Text] [Related]
8. Can selection of rapidly progressing patients shorten clinical trials in amyotrophic lateral sclerosis?
de Carvalho M; Swash M
Arch Neurol; 2006 Apr; 63(4):557-60. PubMed ID: 16606769
[TBL] [Abstract][Full Text] [Related]
9. [Survival in amyotrophic lateral sclerosis].
Alcaz S; Jarebinski M; Pekmezović T; Marinković Z; Apostolski S
Srp Arh Celok Lek; 1997; 125(1-2):19-23. PubMed ID: 17974351
[TBL] [Abstract][Full Text] [Related]
10. Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study.
Chiò A; Calvo A; Bovio G; Canosa A; Bertuzzo D; Galmozzi F; Cugnasco P; Clerico M; De Mercanti S; Bersano E; Cammarosano S; Ilardi A; Manera U; Moglia C; Sideri R; Marinou K; Bottacchi E; Pisano F; Cantello R; Mazzini L; Mora G;
JAMA Neurol; 2014 Sep; 71(9):1134-42. PubMed ID: 25048026
[TBL] [Abstract][Full Text] [Related]
11. An outcome study of riluzole in amyotrophic lateral sclerosis--a population-based study in Ireland, 1996-2000.
Traynor BJ; Alexander M; Corr B; Frost E; Hardiman O
J Neurol; 2003 Apr; 250(4):473-9. PubMed ID: 12700914
[TBL] [Abstract][Full Text] [Related]
12. Incidence of ALS in Lombardy, Italy.
Beghi E; Millul A; Micheli A; Vitelli E; Logroscino G;
Neurology; 2007 Jan; 68(2):141-5. PubMed ID: 17210896
[TBL] [Abstract][Full Text] [Related]
13. The natural history of ALS is changing: improved survival.
Qureshi M; Schoenfeld DA; Paliwal Y; Shui A; Cudkowicz ME
Amyotroph Lateral Scler; 2009; 10(5-6):324-31. PubMed ID: 19922119
[TBL] [Abstract][Full Text] [Related]
14. Predictors of long survival in amyotrophic lateral sclerosis: a population-based study.
Zoccolella S; Beghi E; Palagano G; Fraddosio A; Guerra V; Samarelli V; Lepore V; Simone IL; Lamberti P; Serlenga L; Logroscino G
J Neurol Sci; 2008 May; 268(1-2):28-32. PubMed ID: 18021808
[TBL] [Abstract][Full Text] [Related]
15. Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis.
Turner MR; Bakker M; Sham P; Shaw CE; Leigh PN; Al-Chalabi A
Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Mar; 3(1):15-21. PubMed ID: 12061944
[TBL] [Abstract][Full Text] [Related]
16. [The changes of clinical characteristics in 100 Japanese amyotrophic lateral sclerosis patients between 1980 and 2000].
Kimura F; Shinoda K; Fujiwara S; Fujimura C; Nakajima H; Furutama D; Sugino M; Hanafusa T
Rinsho Shinkeigaku; 2003 Jul; 43(7):385-91. PubMed ID: 14582363
[TBL] [Abstract][Full Text] [Related]
17. Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy.
Zoccolella S; Beghi E; Palagano G; Fraddosio A; Guerra V; Samarelli V; Lepore V; Simone IL; Lamberti P; Serlenga L; Logroscino G;
Eur J Neurol; 2007 Mar; 14(3):262-8. PubMed ID: 17355545
[TBL] [Abstract][Full Text] [Related]
18. Pentoxifylline in ALS: a double-blind, randomized, multicenter, placebo-controlled trial.
Meininger V; Asselain B; Guillet P; Leigh PN; Ludolph A; Lacomblez L; Robberecht W;
Neurology; 2006 Jan; 66(1):88-92. PubMed ID: 16401852
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival in amyotrophic lateral sclerosis: a population-based study.
Pupillo E; Messina P; Logroscino G; Beghi E;
Ann Neurol; 2014 Feb; 75(2):287-97. PubMed ID: 24382602
[TBL] [Abstract][Full Text] [Related]
20. Respiratory systems abnormalities and clinical milestones for patients with amyotrophic lateral sclerosis with emphasis upon survival.
Vender RL; Mauger D; Walsh S; Alam S; Simmons Z
Amyotroph Lateral Scler; 2007 Feb; 8(1):36-41. PubMed ID: 17364434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
